Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for UroGen Pharma (URGN) over the last 7 years, with Q3 2025 value amounting to $160000.0.

  • UroGen Pharma's Amortizatization of Intangibles fell 9302.22% to $160000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 9502.49%. This contributed to the annual value of $2.9 million for FY2024, which is 17959.38% up from last year.
  • Latest data reveals that UroGen Pharma reported Amortizatization of Intangibles of $160000.0 as of Q3 2025, which was down 9302.22% from $866000.0 recorded in Q2 2025.
  • Over the past 5 years, UroGen Pharma's Amortizatization of Intangibles peaked at $2.3 million during Q3 2024, and registered a low of -$961000.0 during Q1 2024.
  • In the last 5 years, UroGen Pharma's Amortizatization of Intangibles had a median value of $238000.0 in 2021 and averaged $443210.5.
  • Within the past 5 years, the most significant YoY rise in UroGen Pharma's Amortizatization of Intangibles was 242075.47% (2024), while the steepest drop was 33787.13% (2024).
  • Over the past 5 years, UroGen Pharma's Amortizatization of Intangibles (Quarter) stood at $238000.0 in 2021, then soared by 184.45% to $677000.0 in 2022, then crashed by 92.17% to $53000.0 in 2023, then surged by 2420.75% to $1.3 million in 2024, then tumbled by 88.02% to $160000.0 in 2025.
  • Its last three reported values are $160000.0 in Q3 2025, $866000.0 for Q2 2025, and $774000.0 during Q1 2025.